DK0535734T3 - Langtidsvirkende injicerbare formuleringer indeholdende hydrogeneret castorolie - Google Patents

Langtidsvirkende injicerbare formuleringer indeholdende hydrogeneret castorolie

Info

Publication number
DK0535734T3
DK0535734T3 DK92202940T DK92202940T DK0535734T3 DK 0535734 T3 DK0535734 T3 DK 0535734T3 DK 92202940 T DK92202940 T DK 92202940T DK 92202940 T DK92202940 T DK 92202940T DK 0535734 T3 DK0535734 T3 DK 0535734T3
Authority
DK
Denmark
Prior art keywords
castor oil
hydrogenated castor
injectable formulations
long
containing hydrogenated
Prior art date
Application number
DK92202940T
Other languages
Danish (da)
English (en)
Inventor
Elinor H Chen
James B Williams
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DK0535734T3 publication Critical patent/DK0535734T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
DK92202940T 1991-09-30 1992-09-24 Langtidsvirkende injicerbare formuleringer indeholdende hydrogeneret castorolie DK0535734T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76879791A 1991-09-30 1991-09-30

Publications (1)

Publication Number Publication Date
DK0535734T3 true DK0535734T3 (da) 1999-08-09

Family

ID=25083508

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92202940T DK0535734T3 (da) 1991-09-30 1992-09-24 Langtidsvirkende injicerbare formuleringer indeholdende hydrogeneret castorolie

Country Status (10)

Country Link
EP (1) EP0535734B1 (de)
JP (1) JPH0672108B2 (de)
AT (1) ATE180671T1 (de)
AU (1) AU2603792A (de)
CA (1) CA2079255A1 (de)
DE (1) DE69229318T2 (de)
DK (1) DK0535734T3 (de)
ES (1) ES2131515T3 (de)
GR (1) GR3030403T3 (de)
ZA (1) ZA927457B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9300883D0 (en) * 1993-01-18 1993-03-10 Pfizer Ltd Antiparasitic agents
US5981500A (en) * 1994-01-12 1999-11-09 Pfizer Inc. Antiparasitic agents related to the milbemycins and avermectins
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
WO1999027906A1 (en) * 1997-12-03 1999-06-10 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated castor oil
US6174540B1 (en) 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
GB9827727D0 (en) 1998-12-16 1999-02-10 Pfizer Ltd Antiparasitic formulations
KR100355116B1 (ko) * 2000-02-17 2002-10-11 주식회사 엘지씨아이 애버멕틴 유도체를 포함하는 기생충 박멸용 사료 프레믹스조성물 및 그 제조방법
KR20020067781A (ko) * 2001-02-19 2002-08-24 주식회사 엘지씨아이 구충용 이버멕틴 주사제 조성물 및 그 제조방법
US6653288B1 (en) 2002-09-30 2003-11-25 Virbac S.A. Injectable anthelmintic compositions and methods for using same
AU2003234895A1 (en) * 2002-11-18 2004-06-15 Yuwan Wang Veterinary antiparasite suspension injection
WO2004103343A1 (fr) * 2003-05-25 2004-12-02 Yuwan Wang Formulation a liberation prolongee a base de dimethicone
WO2005084688A1 (fr) * 2004-03-04 2005-09-15 Yuwan Wang Poudre injectable contenant un vermifuge
US8362086B2 (en) 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
NZ552040A (en) * 2006-12-13 2009-04-30 Bomac Research Ltd Veterinary formulation comprising an anthelmintic compound and glyceryl acetate
CN104168886A (zh) * 2012-03-13 2014-11-26 拜耳新西兰有限公司 长效组合物
CN103705445A (zh) * 2014-01-06 2014-04-09 王玉万 含乙酰甲喹/氢化蓖麻油的原位胶凝注射剂
CN103721266A (zh) * 2014-01-06 2014-04-16 王玉万 含阿维菌素类药物/氢化蓖麻油的原位胶凝注射剂
CN113563395B (zh) * 2021-08-09 2023-06-02 河北威远生物化工有限公司 一种阿维菌素b2衍生物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU596586B2 (en) * 1985-04-30 1990-05-10 American Cyanamid Company Chemical derivatives of antibiotics S541
NZ234802A (en) * 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals

Also Published As

Publication number Publication date
EP0535734B1 (de) 1999-06-02
ZA927457B (en) 1993-04-07
AU2603792A (en) 1993-04-01
ES2131515T3 (es) 1999-08-01
GR3030403T3 (en) 1999-09-30
JPH05246893A (ja) 1993-09-24
EP0535734A1 (de) 1993-04-07
JPH0672108B2 (ja) 1994-09-14
DE69229318T2 (de) 1999-11-18
CA2079255A1 (en) 1993-03-31
ATE180671T1 (de) 1999-06-15
DE69229318D1 (de) 1999-07-08

Similar Documents

Publication Publication Date Title
DK0535734T3 (da) Langtidsvirkende injicerbare formuleringer indeholdende hydrogeneret castorolie
BG104560A (en) Long active injectable formulations containing hydrogenated castor oil
AU681452B2 (en) Pernasal composition and pernasal preparation containing thesame
HUT71889A (en) Pharmaceutical compositions containing terfenadine metabolites and their optically pure isomers for treating allergic disorders
ATE293434T1 (de) Pharmazeutische zusammensetzungen welche kukui nuss öl enthalten
FI955403A0 (fi) Valeltavia koostumuksia, jotka sisältävät polymeerimateriaalia, glykoleja ja glyseridejä
CA2284774A1 (en) Theobromine antitussive compositions
ES2134237T3 (es) Composiciones farmaceuticas que contienen acido ursodesoxicolico.
ATE127683T1 (de) Stabile emulgierte tretinoin-cremeformulierungen.
ATE337333T1 (de) Ophthalmische arzneimittelzusammenstellung
IT1196041B (it) Emichetali di (8s)-8-fluoroeritromicine,il procedimento per la loro preparazione e le formulazioni adatte alla somministrazione orale che contengono i prodotti
EP0535237A4 (en) Composition for relieving skin irritation and external preparation for percutaneous adminstration containing the same
IE810489L (en) Composition for topical application
IE831026L (en) Avermectin formulation